-葡萄糖共运输体2抑制剂和氨酸- ангиотензин-阿尔多斯特系统,可能的细胞相互作用和益处
Behina Forouzanmehr1, Amir Hossein Hedayati1, Emad Gholami1
1Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran.
Cellular signalling
|August 8, 2024
概括
糖携运输体2抑制剂 (SGLT2is) 提供血糖控制,并可能影响氨酸-氨酸-氨系统 (RAAS). 本综述探讨了SGLT2is如何影响RAAS活动,表明对脏和心脏健康的潜在益处.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
背景情况:
- 糖携带体2抑制剂 (SGLT2is) 是有效的抗糖尿病药物,具有已知的低血糖作用.
- 新出现的证据表明,SGLT2is具有额外的葡萄糖益处,特别是在氨酸-血管氨酸-氨系统 (RAAS) 中.
- 调节RAAS对于治疗糖尿病患者影响脏和心血管系统的并发症至关重要.
研究的目的:
- 研究SGLT2抑制剂调节RAAS活性的潜在分子机制.
- 巩固目前对SGLT2抑制和RAAS之间的相互作用的理解.
主要方法:
- 现有研究的文献调查.
- 分析SGLT2抑制和RAAS之间的分子相互作用.
主要成果:
- SGLT2is显示出超出血糖控制的RAAS活动的潜在调节效应.
- 这些效应表明SGLT2是治疗脏和心血管疾病的有希望的药物.
结论:
- 通过影响RAAS,SGLT2抑制剂可能为糖尿病患者提供显著的治疗优势.
- 需要进一步的研究,以充分阐明将SGLT2抑制与RAAS调节联系在一起的分子机制.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
517
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
517
Antihypertensive Drugs: Angiotensin II Receptor Blockers
666
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
666
Secondary Active Transport
118.8K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
118.8K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
569
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
569
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Antihypertensive Drugs: Potassium-Sparing Diuretics
488
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
488


